Search Results 1571-1580 of 18447 for Immunode

1. A Trial of Verdiperstat in Patients With svPPA Due to TDP-43 Pathology (Veri-T-001) - Mayo Clinic

   Current clinically significant viral infection, including "known" positive status for human immunodeficiency virus (HIV) (i.e., based on prior testing; HIV ...

2. Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Hydrochloride Before Surgery in Treating Patients With Newly Diagnosed Non-Rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery - Mayo Clinic

   Human immunodeficiency virus (HIV)-positive subjects on combination antiretroviral therapy; Patients who are receiving any other investigational agent(s) ...

3. A Phase 2 Study of Anti-PD-L1 Antibody Atezolizumab in Alveolar Soft Part Sarcoma - Mayo Clinic

   Human immunodeficiency virus (HIV)-positive patients on combination antiretroviral therapy are ineligible; patients must also have a CD4 count > 350 cells ...

4. A Study of Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic Adenocarcinoma - Mayo Clinic

   Known infection with Human Immunodeficiency Virus (HIV), and/or active infection with hepatitis B, or hepatitis C. History of interstitial lung disease ...

5. GEN3013, Epcoritamab Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma EPCORE™ NHL-1 - Mayo Clinic

   Known human immunodeficiency virus (HIV) infection. Exposed to live or live attenuated vaccine within 4 weeks prior to signing ICF. Pregnancy or breast ...

6. Nathan W. Cummins, M.D. - Mayo Clinic Faculty Profiles

   Areas of Research. Human Immunodeficiency Virus - Andrew D. Badley · Infectious Diseases Research · Biomedical Ethics Research Program. More about research at ...

7. Sapanisertib in Treating Patients With Metastatic or Refractory Pancreatic Neuroendocrine Tumor That Cannot Be Removed by Surgery - Mayo Clinic

   No ongoing requirement for dexamethasone or anti-epileptic drugs. Human immunodeficiency virus (HIV)-positive patients on combination antiretroviral therapy are ...

8. Ixazomib Citrate in Treating Patients With Relapsed Multiple Myeloma That Is Not Refractory to Bortezomib - Mayo Clinic

   Known human immunodeficiency virus (HIV) positive. Known hepatitis B surface antigen-positive status, or known or suspected active hepatitis C infection ...

9. Single-Ascending Dose Study of JK07 in Subjects With HFpEF - Mayo Clinic

   adjusted within 2 months prior to informed consent. 22. Positive screening for human immunodeficiency virus antibodies, hepatitis B surface antigen, or ...

10. A Study to Assess Epicardial Delivery of XC001 Gene Therapy for Refractory Angina Coronary Treatment (The EXACT Trial) - Mayo Clinic

    A history or evidence of human immunodeficiency virus (HIV) on screening or active hepatitis C virus (HCV), active hepatitis B virus (HBV) or active COVID-19 ...